rinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity in Patients with Chronic Renal Disease - Urinary Angiotensinogen in Chronic Renal Disease

Hamamatsu University School of Medicine0 个研究点目标入组 80 人开始时间: 2005年9月13日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方: Hamamatsu University School of Medicine
入组人数: 80

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The results showing that urinary angiotensinogen levels could be used as a marker of intrarenal angiotensin II activity associated with increased risk for deterioration of renal function in patients with chronic kidney disease has been published in J. Am. Soc. Nephrol. 18:1558-1565, 2007.

研究设计

研究类型: Observational

入排标准

年龄范围: 16years-old 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•Patients treated with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers

研究者

发起方

Hamamatsu University School of Medicine

相似试验

Unknown

不适用

Study of Urinary Angiotensinogen as a Marker to Warn the Deterioration of Renal Function in CKD Patients Early.Urinary AngiotensinogenChronic Kidney Disease

NCT01118494Fudan University400

招募中

不适用

rinary angiotensinogen (AGT) becomes a biomarker for the selection of optimal antihypertensive drugsHypertension

JPRN-UMIN000010931Kagawa University, Faculty of Medicine150

进行中（未招募）

不适用

OUTREACH study: Urine analysis and antihypertensive treatmentCirculatory SystemHypertensionCardiovascular disease

ISRCTN15911100The University of Manchester240

终止

不适用

Study of Renin-angiotensin System in Mechanically Ventilated SubjectsAcute Lung Injury

NCT03212690GlaxoSmithKline57

招募中

不适用

Evaluation of plasma angiotensinogen(AGT) and the effect of DRI on AGT and RAAS in hemodialysis patientsHemodialysis patients Hypertension

JPRN-UMIN000006479Kagawa University, Faculty of Medicine40